Anti-Infective Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1062737
  • May 2021
  • Pharmaceuticals
  • 120 Pages
The Anti-Infective Drugs market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Anti-Infective Drugs market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Merck & Co., Inc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Hetero, Mylan N.V., Aurobindo Pharma, Cipla Inc, Laurus Labs Ltd, Micro Labs Ltd, Inc, Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Pharma, Bausch Health
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Anti-Infective Drugs market along with their effects over the forecast period. Similarly, according to the region Anti-Infective Drugs market research report includes the study of opportunities available in the market situation.

The Anti-Infective Drugs market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Anti-Infective Drugs Market:
The Anti-Infective Drugs market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Merck & Co., Inc, F. Hoffmann-La Roche Ltd, Pfizer Inc, Johnson & Johnson Services, Inc, GlaxoSmithKline plc, Hetero, Mylan N.V., Aurobindo Pharma, Cipla Inc, Laurus Labs Ltd, Micro Labs Ltd, Inc, Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Lupin, Novartis AG, Zydus Pharma, Bausch Health

Anti-Infective Drugs Market Segmentation Analysis:
By Type
RIDT
Viral Culture
DFA
Serological Assays
Application
Hospitals
Clinical Laboratories
Others


Global Anti-Infective Drugs Market Segmentation by Regions:
In regional analysis, Anti-Infective Drugs market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Anti-Infective Drugs market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Anti-Infective Drugs Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Anti-Infective Drugs Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Anti-Infective Drugs Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Anti-Infective Drugs Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Anti-Infective Drugs Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Anti-Infective Drugs market, according to the key region.
  • To study the Anti-Infective Drugs market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Anti-Infective Drugs market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Anti-Infective Drugs research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Anti-Infective Drugs market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Anti-Infective Drugs market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Anti-Infective Drugs market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Anti-Infective Drugs market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Anti-Infective Drugs market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Johnson & Johnson Services, Inc
  • GlaxoSmithKline plc
  • Hetero
  • Mylan N.V.
  • Aurobindo Pharma
  • Cipla Inc
  • Laurus Labs Ltd
  • Micro Labs Ltd, Inc
  • Gilead Sciences, Inc
  • Sun Pharmaceutical Industries Ltd
  • Amneal Pharmaceuticals LLC
  • Alembic Pharmaceuticals Limited
  • Lupin
  • Novartis AG
  • Zydus Pharma
  • Bausch Health
  • RIDT
  • Viral Culture
  • DFA
  • Serological Assays
  • Hospitals
  • Clinical Laboratories
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Anti-Infective Drugs Market Snapshot
          2.1.1. Global Anti-Infective Drugs Market By Type,2019
               2.1.1.1.RIDT
               2.1.1.2.Viral Culture
               2.1.1.3.DFA
               2.1.1.4.Serological Assays
          2.1.2. Global Anti-Infective Drugs Market By Application,2019
               2.1.2.1.Hospitals
               2.1.2.2.Clinical Laboratories
               2.1.2.3.Others
          2.1.3. Global Anti-Infective Drugs Market By End-use,2019
          2.1.4. Global Anti-Infective Drugs Market By Geography,2019

3. Global Anti-Infective Drugs Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028

5. Global Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028

6. Global Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028

7. Global Anti-Infective Drugs Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Anti-Infective Drugs Market Analysis, 2018 – 2028 
          7.2.1. North America Anti-Infective Drugs Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Anti-Infective Drugs Market Analysis, 2018 – 2028 
          7.3.1.  Europe Anti-Infective Drugs Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Anti-Infective Drugs Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Anti-Infective Drugs Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Anti-Infective Drugs Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Anti-Infective Drugs Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Anti-Infective Drugs Market Analysis, 2018 – 2028 
          7.6.1.  MEA Anti-Infective Drugs Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Anti-Infective Drugs Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Anti-Infective Drugs Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Anti-Infective Drugs Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Anti-Infective Drugs Providers
        8.4.1 Merck & Co., Inc
                8.4.1.1 Business Description
                8.4.1.2 Merck & Co., Inc Geographic Operations
                8.4.1.3 Merck & Co., Inc Financial Information
                8.4.1.4 Merck & Co., Inc Product Positions/Portfolio
                8.4.1.5 Merck & Co., Inc Key Developments
        8.4.2 F. Hoffmann-La Roche Ltd
                8.4.2.1 Business Description
                8.4.2.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.2.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.2.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.2.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.3 Pfizer Inc
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Inc Geographic Operations
                8.4.3.3 Pfizer Inc Financial Information
                8.4.3.4 Pfizer Inc Product Positions/Portfolio
                8.4.3.5 Pfizer Inc Key Developments
        8.4.4 Johnson & Johnson Services, Inc
                8.4.4.1 Business Description
                8.4.4.2 Johnson & Johnson Services, Inc Geographic Operations
                8.4.4.3 Johnson & Johnson Services, Inc Financial Information
                8.4.4.4 Johnson & Johnson Services, Inc Product Positions/Portfolio
                8.4.4.5 Johnson & Johnson Services, Inc Key Developments
        8.4.5 GlaxoSmithKline plc
                8.4.5.1 Business Description
                8.4.5.2 GlaxoSmithKline plc Geographic Operations
                8.4.5.3 GlaxoSmithKline plc Financial Information
                8.4.5.4 GlaxoSmithKline plc Product Positions/Portfolio
                8.4.5.5 GlaxoSmithKline plc Key Developments
        8.4.6 Hetero
                8.4.6.1 Business Description
                8.4.6.2 Hetero Geographic Operations
                8.4.6.3 Hetero Financial Information
                8.4.6.4 Hetero Product Positions/Portfolio
                8.4.6.5 Hetero Key Developments
        8.4.7 Mylan N.V.
                8.4.7.1 Business Description
                8.4.7.2 Mylan N.V. Geographic Operations
                8.4.7.3 Mylan N.V. Financial Information
                8.4.7.4 Mylan N.V. Product Positions/Portfolio
                8.4.7.5 Mylan N.V. Key Developments
        8.4.8 Aurobindo Pharma
                8.4.8.1 Business Description
                8.4.8.2 Aurobindo Pharma Geographic Operations
                8.4.8.3 Aurobindo Pharma Financial Information
                8.4.8.4 Aurobindo Pharma Product Positions/Portfolio
                8.4.8.5 Aurobindo Pharma Key Developments
        8.4.9 Cipla Inc
                8.4.9.1 Business Description
                8.4.9.2 Cipla Inc Geographic Operations
                8.4.9.3 Cipla Inc Financial Information
                8.4.9.4 Cipla Inc Product Positions/Portfolio
                8.4.9.5 Cipla Inc Key Developments
        8.4.10 Laurus Labs Ltd
                8.4.10.1 Business Description
                8.4.10.2 Laurus Labs Ltd Geographic Operations
                8.4.10.3 Laurus Labs Ltd Financial Information
                8.4.10.4 Laurus Labs Ltd Product Positions/Portfolio
                8.4.10.5 Laurus Labs Ltd Key Developments
        8.4.11 Micro Labs Ltd, Inc
                8.4.11.1 Business Description
                8.4.11.2 Micro Labs Ltd, Inc Geographic Operations
                8.4.11.3 Micro Labs Ltd, Inc Financial Information
                8.4.11.4 Micro Labs Ltd, Inc Product Positions/Portfolio
                8.4.11.5 Micro Labs Ltd, Inc Key Developments
        8.4.12 Gilead Sciences, Inc
                8.4.12.1 Business Description
                8.4.12.2 Gilead Sciences, Inc Geographic Operations
                8.4.12.3 Gilead Sciences, Inc Financial Information
                8.4.12.4 Gilead Sciences, Inc Product Positions/Portfolio
                8.4.12.5 Gilead Sciences, Inc Key Developments
        8.4.13 Sun Pharmaceutical Industries Ltd
                8.4.13.1 Business Description
                8.4.13.2 Sun Pharmaceutical Industries Ltd Geographic Operations
                8.4.13.3 Sun Pharmaceutical Industries Ltd Financial Information
                8.4.13.4 Sun Pharmaceutical Industries Ltd Product Positions/Portfolio
                8.4.13.5 Sun Pharmaceutical Industries Ltd Key Developments
        8.4.14 Amneal Pharmaceuticals LLC
                8.4.14.1 Business Description
                8.4.14.2 Amneal Pharmaceuticals LLC Geographic Operations
                8.4.14.3 Amneal Pharmaceuticals LLC Financial Information
                8.4.14.4 Amneal Pharmaceuticals LLC Product Positions/Portfolio
                8.4.14.5 Amneal Pharmaceuticals LLC Key Developments
        8.4.15 Alembic Pharmaceuticals Limited
                8.4.15.1 Business Description
                8.4.15.2 Alembic Pharmaceuticals Limited Geographic Operations
                8.4.15.3 Alembic Pharmaceuticals Limited Financial Information
                8.4.15.4 Alembic Pharmaceuticals Limited Product Positions/Portfolio
                8.4.15.5 Alembic Pharmaceuticals Limited Key Developments
        8.4.16 Lupin
                8.4.16.1 Business Description
                8.4.16.2 Lupin Geographic Operations
                8.4.16.3 Lupin Financial Information
                8.4.16.4 Lupin Product Positions/Portfolio
                8.4.16.5 Lupin Key Developments
        8.4.17 Novartis AG
                8.4.17.1 Business Description
                8.4.17.2 Novartis AG Geographic Operations
                8.4.17.3 Novartis AG Financial Information
                8.4.17.4 Novartis AG Product Positions/Portfolio
                8.4.17.5 Novartis AG Key Developments
        8.4.18 Zydus Pharma
                8.4.18.1 Business Description
                8.4.18.2 Zydus Pharma Geographic Operations
                8.4.18.3 Zydus Pharma Financial Information
                8.4.18.4 Zydus Pharma Product Positions/Portfolio
                8.4.18.5 Zydus Pharma Key Developments
        8.4.19 Bausch Health
                8.4.19.1 Business Description
                8.4.19.2 Bausch Health Geographic Operations
                8.4.19.3 Bausch Health Financial Information
                8.4.19.4 Bausch Health Product Positions/Portfolio
                8.4.19.5 Bausch Health Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Anti-Infective Drugs Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Anti-Infective Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Anti-Infective Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Anti-Infective Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Anti-Infective Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Anti-Infective Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Anti-Infective Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Anti-Infective Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Anti-Infective Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Anti-Infective Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Anti-Infective Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Anti-Infective Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Anti-Infective Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Anti-Infective Drugs Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Anti-Infective Drugs Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Anti-Infective Drugs Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Anti-Infective Drugs: Market Segmentation 
FIG. 2 Global Anti-Infective Drugs Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Anti-Infective Drugs Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Anti-Infective Drugs Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Anti-Infective Drugs Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Anti-Infective Drugs Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Anti-Infective Drugs Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Anti-Infective Drugs Providers, 2019
FIG. 11 Global Anti-Infective Drugs Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Anti-Infective Drugs Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Anti-Infective Drugs Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Anti-Infective Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Anti-Infective Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Anti-Infective Drugs Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Anti-Infective Drugs Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Anti-Infective Drugs Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Anti-Infective Drugs market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Anti-Infective Drugs Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Anti-Infective Drugs Market Value, By Segment1, 2018 – 2028
TABLE  North America Anti-Infective Drugs Market Value, By Segment2, 2018 – 2028
TABLE  North America Anti-Infective Drugs Market Value, By Country, 2018 – 2028
TABLE  Europe Anti-Infective Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Europe Anti-Infective Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Europe Anti-Infective Drugs Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Anti-Infective Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Anti-Infective Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Anti-Infective Drugs Market Value, By Country, 2018 – 2028
TABLE  Latin America Anti-Infective Drugs Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Anti-Infective Drugs Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Anti-Infective Drugs Market Value, By Country, 2018 – 2028
TABLE  MEA Anti-Infective Drugs Market Value, By Segment1, 2018 – 2028
TABLE  MEA Anti-Infective Drugs Market Value, By Segment2, 2018 – 2028
TABLE  MEA Anti-Infective Drugs Market Value, By Country, 2018 – 2028
TABLE  Merck & Co., Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson & Johnson Services, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hetero: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mylan N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Aurobindo Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Laurus Labs Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Micro Labs Ltd, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Gilead Sciences, Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sun Pharmaceutical Industries Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Amneal Pharmaceuticals LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Alembic Pharmaceuticals Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lupin: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Novartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zydus Pharma: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bausch Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Anti-Infective Drugs Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Anti-Infective Drugs Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Anti-Infective Drugs Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Anti-Infective Drugs Market, By Geography, 2019 (US$ Mn)
FIG.  Global Anti-Infective Drugs Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Anti-Infective Drugs Providers, 2016
FIG.  Global Anti-Infective Drugs Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Viral Culture Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global DFA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Serological Assays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Anti-Infective Drugs Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinical Laboratories Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Anti-Infective Drugs Market Value, 2018 – 2028, (US$ Mn)